Pieris Pharmaceuticals - PIRS Operatsion marja

Ommaviy kompaniya Pieris Pharmaceuticals Inc (PIRS) logotipi

Pieris Pharmaceuticals (PIRS) Anticalin proteinlaridan foydalanadigan strategik ittifoqlar orqali respirator va onkologik dori vositalarini ishlab chiqmoqda. Asosiy faoliyatdan olingan marjinal daromadlar bozor dinamikasini aks ettiradi, bunda 0.00 yakuniy daraja belgisi vazifasini o'taydi. Kompaniyaning kapitali global hamkorlardan olinadigan royalti va oldindan to'lovlarga tayanadi, garchi qat'iy shtat qisqartirishlari va testlarning muzlatilishi yuqori infratuzilma xarajatlari fonida himoya to'sig'ini yaratgan bo'lsa-da.

Pieris Pharmaceuticals Inc (PIRS): Operatsion faoliyat rentabelligi 04.07.2022dan 19.11.2026gacha

Pieris Pharmaceuticals (PIRS) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- narx va narxlar bo'yicha konsensus prognoz:
- emitentning bozor qiymati haqida ma'lumotlar:
Kompaniyaning fundamental baholanishi:Pieris Pharmaceuticals Inc, PIRS
Pieris Pharma asosiy tovari

Pieris Pharmaceuticals (PIRS) kompaniyasining tadqiqot va ishlanmalarni ( R&D ) autsorsing qilish orqali xarajatlarni optimallashtirishi, o'rtacha operatsion marjada aniq aks etganidek, bevosita asosiy operatsion samaradorlikka ta'sir qiladi. Ushbu ko'rsatkich moliyaviy va soliq majburiyatlarigacha bo'lgan asosiy biznesdan olingan foyda ulushini o'lchaydi, bu esa investorlarga buxgalteriya buzilishlarini olib tashlash va sanoatning potentsial qisqarishi oldidan aktivning haqiqiy daromadliligini aniqlash imkonini beradi.

Asosiy raqobatchilar

Operatsion rentabellik haleon.com|Operatsion rentabellik KVUE|Operatsion rentabellik Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operatsion foyda bo'yicha marjinallik|Operatsion marja LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operatsion rentabellik|PRGO - Operatsion rentabellik|Alvotech Corp (ALVO) - Sotuvning operatsion marjasi|LQDA: Operatsion marja|Sotuvning operatsion rentabelligi glpg.com (GLPG)|Operatsion rentabellik ANI Pharmaceuticals Inc|MNKD: Operatsion foyda normasi|Sotuvning operatsion marjasi AMPH (Amphastar)|PCRX - Sotuvning operatsion rentabelligi|Operatsion marja SPRY (ars-pharma.com)|Operatsion foyda normasi TBPH|Aquestive Therapeutics, Inc. - Operatsion marja|scpharmaceuticals.com - Operatsion foyda koeffitsiyenti|Tectonic (TECX) - Operatsion rentabellik|Sotuvning operatsion marjasi Tonix Pharmaceuticals Inc.|Operatsion rentabellik sxtchina.com|Sotuvning operatsion marjasi Eupraxia Pharmaceuticals (EPRX)|Operatsion marja BHST|EXOZ - Sotuvning operatsion rentabelligi|Oramed - Sotuvning operatsion marjasi|Entera Bio Ltd. (ENTX) - Sotuvning operatsion rentabelligi|HYFT - Operatsion rentabellik|ABVC: Operatsion rentabellik|CPIX: Operatsion marja|Quantum BioPharma Ltd. - Operatsion foyda normasi|FGEN (FibroGen Corp) - Operatsion marja|Telomir Pharma (TELO) - Operatsion faoliyat rentabelligi|Operatsion rentabellik Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operatsion foyda normasi|Operatsion rentabellik Rallybio Corporation RLYB|LEXX: Operatsion foyda bo'yicha sotuv rentabelligi|PULM - Operatsion rentabellik|Operatsion foyda normasi PTHL (Pheton Holdings)|Aptorum (APM) - Operatsion rentabellik|LYRA (Lyra Therapeutics) - Operatsion rentabellik|Operatsion rentabellik Impact BioMedical Inc|TNF Pharmaceuticals - Operatsion foyda marjasi|Operatsion marja YCBD|Operatsion marja PainReform Ltd. (PRFX)|Operatsion rentabellik Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Operatsion foyda marjasi|OptiNose - Operatsion marja|Procaps (PROC) - Sotuvning operatsion marjasi|PTPI: Operatsion marja|Qilian International (QLI) - Operatsion marja|Operatsion rentabellik Acelyrin, Inc.|Operatsion marja TFF Pharmaceuticals, Inc.